Back to Search Start Over

Correlating Vestibular Migraine Patient Assessment Tool and Handicap Inventory to Daily Dizziness Symptoms.

Authors :
Kim EK
Hum M
Sharon JD
Source :
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology [Otol Neurotol] 2023 Dec 01; Vol. 44 (10), pp. 1052-1056. Date of Electronic Publication: 2023 Sep 15.
Publication Year :
2023

Abstract

Objective: Investigate the relationship between Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) scores and daily dizziness symptoms.<br />Study Design: Prospective cohort analysis of 52 patients with vestibular migraine (VM).<br />Setting: Tertiary referral center.<br />Patients: Fifty-two patients diagnosed with VM or probable VM according to Barany Society criteria.<br />Interventions: Subjects reported their dizzy symptoms (on a scale of 0 [no symptoms], 1 [mild], 2 [moderate], and 3 [severe]) every day for 1 month via automated text messaging linked to a cloud-based research database. Subjects completed VM-PATHI and Dizziness Handicap Inventory (DHI) scores at the end of the month. We examined the correlation between a composite of daily dizziness scores with VM-PATHI and DHI scores through linear regression and correlation analysis.<br />Main Outcome Measures: Pearson correlation coefficient, R2 value.<br />Results: VM-PATHI showed a moderate correlation with daily dizziness symptoms (correlation coefficient, 0.51). DHI showed a lower correlation with daily dizziness (correlation coefficient, 0.38). VM-PATHI score was a strong predictor of daily dizziness with univariate linear regression ( R2 = 0.26, p = 0.001). In a multiple linear regression model with age, history of anxiety and/or depression, and VM-PATHI, the VM-PATHI score was the only statistically significant predictor of daily dizziness ( p < 0.001).<br />Conclusions: Daily dizziness symptoms are better correlated with VM-PATHI score than the DHI, providing further validation of VM-PATHI as a disease-specific outcome measure for patients with VM.<br />Competing Interests: Sources of support and disclosure of funding: Dr. Sharon receives research support from Advanced Bionics and Eli Lilly and is a paid consultant for Spiral Therapeutics. All other authors have no conflicts of interest or sources of funding to disclose.<br /> (Copyright © 2023, Otology & Neurotology, Inc.)

Details

Language :
English
ISSN :
1537-4505
Volume :
44
Issue :
10
Database :
MEDLINE
Journal :
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Publication Type :
Academic Journal
Accession number :
37733970
Full Text :
https://doi.org/10.1097/MAO.0000000000004014